FDA Approves Vaxneuvance Pneumococcal Vaccine for Infants, Children
The FDA has expanded the approval for Merck's Vaxneuvance for prevention of invasive disease caused by Streptococcus pneumoniae to include children 6 weeks through 17 years of age.
The FDA has expanded the approval for Merck's Vaxneuvance for prevention of invasive disease caused by Streptococcus pneumoniae to include children 6 weeks through 17 years of age.
An investigational RSV vaccine administered to pregnant women reduced RSV-associated lower respiratory tract infections and subsequent antibiotic prescriptions among their infants.
A genetic variant in a surfactant-producing protein led to a fatal case of interstitial lung disease in a two-year-old child, according to an analysis of the child's lung tissue.
Women who receive COVID-19 mRNA vaccines during pregnancy pass high levels of antibodies to their babies, new research from NYU Langone shows.
Read MoreFor the first time researchers have shown a link between lower lung function in babies born to physically inactive mothers compared to those born to active mothers.
Read MoreAn enzyme called protein phosphatase 2 (PP2A) appears to be a major driver of preeclampsia, a dangerous pregnancy complication characterized by the development of high blood pressure and excess protein in the urine.
Read MoreB&B Medical Technologies’ Baby Tape Plus is a pre-cut endotracheal tube holder made from a non-irritating, latex free hydrocolloid adhesive that is skin friendly for infants.
Read MoreInfants and children are very susceptible to RSV infection and the most serious cases (usually involving bronchiolitis or pneumonia) will be admitted to NICU/PICU.
Read MoreWomen who use electronic cigarettes during pregnancy are 33% more likely than those who don’t to give birth to low-birthweight infants, according to a new study published in the journal Obstetrics & Gynecology.
Read MoreMV-012-968 is an intranasal live attenuated RSV vaccine candidate being developed as a needle-free, adjuvant-free vaccine to protect infants and at-risk, older adults.
Read MoreThe FDA is expected to authorize the Pfizer/BioNTech COVID-19 vaccination for children ages 12-15 as early as this week, and the company plans to request authorization for ages 2-11 this fall.
Read MorePulse oximetry-based critical congenital heart disease screening using Masimo SET had higher CCHD screening sensitivity than physical exam.
Read MoreThe interhospital transport of infants with persistent pulmonary hypertension of the newborn (PPHN) being administered inhaled nitric oxide therapy requires specialized, intensive care.
Read MorePregnant women infected with COVID-19 who were either asymptomatic or symptomatic passed SARS-CoV-2 antibodies to their newborns during pregnancy via the placenta.
Read MoreResearch suggests that compared to vaginally-born children, cesarean-born children may have a higher risk of infection-related hospitalization for up to five years of age.
Read More